<?xml version='1.0' encoding='UTF-8'?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:ccmbenchmark="https://www.ccmbenchmark.com/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>H&amp;eacute;l&amp;egrave;ne Assir : Dernier contenus</title><link>/account/helene-assir-25130</link><atom:link href="/account/helene-assir-25130" rel="self" type="application/rss+xml" /><language>fr</language><pubDate>Sat, 30 May 2026 18:10:33 +0200</pubDate><lastBuildDate>Sat, 30 May 2026 18:10:33 +0200</lastBuildDate><item><title>La révolution data driven dans l’industrie pharmaceutique</title><link>https://www.journaldunet.com/solutions/analytics/1194626-la-revolution-data-driven-dans-l-industrie-pharmaceutique/</link><description><![CDATA[<a href="https://www.journaldunet.com/solutions/analytics/1194626-la-revolution-data-driven-dans-l-industrie-pharmaceutique/"><img src="https://img-0.journaldunet.com/8K3CQobiyFS7cLzckmrz00da7wY=/100x/smart/1c8036611c204404a8e316fd308583f1/user-jdn/10020053-anonyme-anonyme.jpg" align="left" hspace="5" vspace="0"></a>Si l’industrie pharmaceutique a par nature adopté depuis fort longtemps une démarche « evidence-based » dans les domaines de la R&D, ces approches, aussi dites « data-driven », sont bien plus récentes dans l’élaboration des stratégies commerciales et marketing.]]></description><pubDate>Thu, 18 May 2017 14:42:35 +0200</pubDate><guid>https://www.journaldunet.com/solutions/analytics/1194626-la-revolution-data-driven-dans-l-industrie-pharmaceutique/</guid><dc:creator><![CDATA[H&eacute;l&egrave;ne Assir]]></dc:creator><ccmbenchmark:content_author><![CDATA[H&eacute;l&egrave;ne Assir]]></ccmbenchmark:content_author><ccmbenchmark:content_author_company><![CDATA[COHERIS]]></ccmbenchmark:content_author_company><ccmbenchmark:content_author_illustration>1</ccmbenchmark:content_author_illustration></item></channel></rss>